₩53,700.00 ($39.97)

-2600.00 (-4.62%)

Weekly Expected Move ±10.6%

₩42317 ₩48009 ₩53700 ₩59391 ₩65083

KOE · Healthcare · Medical - Devices · Tech Score Buy · Power 60 · ₩1.32T mcap · 19M float · 1.62% daily turnover

Revenue

$85.5B +18.6% ▲

5Y CAGR: +21.0%

Gross Profit

$41.3B +15.7% ▲

5Y CAGR: +16.1%

Operating Income

$3.4B +35.4% ▲

5Y CAGR: -14.0%

Net Income

-$138.2B -198.0% ▼

EPS (Diluted)

$-5811.40 -201.5% ▼

EBITDA

$11.6B -92.2% ▼

5Y CAGR: +3.2%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$45.7B	$52.6B	$68.9B	$72.1B	$85.5B
YoY Growth	+38.5%	+15.1%	+31.0%	+4.7%	+18.6%
Cost of Revenue	$17.2B	$25.6B	$32.1B	$36.4B	$44.2B
Gross Profit	$28.5B	$27.0B	$33.9B	$35.7B	$41.3B
Gross Margin	62.3%	51.3%	49.2%	49.6%	48.3%
R&D Expenses	$2.3B	$2.2B	$3.2B	$4.9B	$0
SG&A Expenses	$12.1B	$13.9B	$20.5B	$18.2B	$0
Operating Expenses	$14.4B	$17.5B	$25.7B	$33.2B	$37.9B
Operating Income	$13.2B	$9.5B	$7.0B	$2.5B	$3.4B
Operating Margin	28.8%	18.0%	10.2%	3.5%	4.0%
Interest Expense	$460M	$3.1B	$6.2B	$3.2B	$5.9B
Income Before Tax	$17.1B	$4.6B	$62.9B	$137.8B	-$160.0B
Tax Expense	$1.5B	-$1.1B	$14.4B	-$5.4B	-$21.7B
Net Income	$13.8B	$4.5B	$48.4B	$141.1B	-$138.2B
Net Margin	30.2%	8.6%	70.2%	195.7%	-161.7%
EPS (Diluted)	$619.55	$200.32	$2106.72	$5727.24	$-5811.40
EBITDA	$16.7B	$14.2B	$14.8B	$147.8B	$11.6B
Shares Outstanding	22M	23M	25M	25M	25M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$18.5B	$19.1B	$17.8B	$20.6B	$22.6B	$24.7B	$30.3B	$38.8B
Cost of Revenue	$9.5B	$9.9B	$7.9B	$11.2B	$9.4B	$11.6B	$12.3B	$16.5B
Gross Profit	$9.1B	$9.2B	$9.8B	$9.4B	$13.2B	$13.1B	$18.0B	$22.3B
Gross Margin	49.0%	48.0%	55.4%	45.5%	58.4%	53.1%	59.3%	57.6%
R&D Expenses	$1.0B	$1.9B	$1.2B	$932M	$881M	$1.0B	$1.1B	$0
SG&A Expenses	$8.9B	$5.6B	$10.3B	$9.6B	$5.8B	$6.4B	$12.4B	$8.7B
Operating Expenses	$8.9B	$9.8B	$10.3B	$9.6B	$10.3B	$11.1B	$12.0B	$13.7B
Operating Income	$175M	-$622M	-$433M	-$245M	$2.9B	$2.0B	$6.0B	$8.6B
Operating Margin	0.9%	-3.3%	-2.4%	-1.2%	12.8%	7.9%	19.8%	22.1%
Interest Expense	$4.9B	$9.2B	$1.3B	$20.0B	$76.4B	-$91.8B	$4.4B	$1.1B
Income Before Tax	-$5.7B	$139.9B	-$872M	-$14.0B	-$51.3B	-$94.0B	$3.0B	-$7.1B
Tax Expense	$116M	-$6.1B	-$229M	$74M	$7M	-$21.5B	$286M	$21.0B
Net Income	-$5.2B	$143.6B	-$428M	-$13.7B	-$51.5B	-$72.6B	$2.6B	-$28.1B
Net Margin	-27.9%	752.4%	-2.4%	-66.7%	-228.1%	-294.1%	8.6%	-72.5%
EPS (Diluted)	$-228.00	$6402.77	$-18.85	$-605.33	$-2289.00	$-2947.15	$104.76	$-1038.16
EBITDA	$2.5B	$139.2B	$2.4B	$11.4B	$5.0B	-$7.2B	$8.1B	$11.2B
Shares Outstanding	23M	23M	23M	23M	22M	25M	26M	27M

290650.KQ KOE